Patents by Inventor Aaron Scalia

Aaron Scalia has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • GMG-3 GMG-4 and GMG-6 polynucleotides and polypeptides and uses thereof
    Patent number: 7326678
    Abstract: The present invention relates to the field of metabolic research. Metabolic disorders, such as obesity, are a public health problem that is serious and widespread. GMG-3, GMG-4, Cluster 1, GMG-6A, or GMG-6B polypeptides have been identified that are beneficial in the treatment of metabolic disorders. These compounds should be effective for reducing body mass and for treating metabolic-related diseases and disorders. These metabolic-related diseases and disorders include hyperlipidemias, atherosclerosis, diabetes, and hypertension.
    Type: Grant
    Filed: January 15, 2002
    Date of Patent: February 5, 2008
    Assignee: Serono Genetics Institute S.A.
    Inventors: Mary Ruth Erickson, Barbara A. Chicca, Bernard Bihain, Hiroaki Tanaka, Tom Chu, Deno P. Dialynas, Aaron Scalia
  • Gmg-2 polynucleotides and polypeptides and uses thereof
    Publication number: 20060293225
    Abstract: The present invention relates to the field of obesity research. Obesity is a public health problem that is serious and widespread. A compound, homotrimer of GMG-2 polypeptide fragment comprising globular domain and all or part of GMG-2 collagen-like region, has been identified that has utility for reducing body mass, for maintaining weight loss, and for treating obesity-related diseases and disorders. These obesity-related diseases and disorders include hyperlipidemias, atherosclerosis, diabetes, and hypertension.
    Type: Application
    Filed: July 25, 2002
    Publication date: December 28, 2006
    Applicant: GENSET S.A.
    Inventors: Deno Dialynas, John Lucas, Aaron Scalia, Hiroaki Tanaka
  • Xcrf polynucleotides and polypeptides and uses thereof
    Publication number: 20060258567
    Abstract: The present invention relates to the field of metabolic research. Metabolic disorders, such as obesity, are a public health problem that is serious and widespread. XCRF polypeptides have been identified that are beneficial in the treatment of metabolic disorders. These compounds should be effective for reducing body mass and for treating metabolic-related diseases and disorders. These metabolic-related diseases and disorders include hyperlipidemias, atherosclerosis, diabetes, and hypertension.
    Type: Application
    Filed: March 26, 2003
    Publication date: November 16, 2006
    Applicant: SERONO GENETICS INSTITITE S.A.
    Inventors: Kristen Briggs, Deno Dialynas, John Lucas, Aaron Scalia
  • Agonists and antagonists of ryzn for the treatment of metabolic disorders
    Publication number: 20060089311
    Abstract: The present invention relates to the field of metabolic research, in particular the discovery of compounds effective for reducing body mass and useful for treating obesity-related diseases and disorders. The obesity-related diseases or disorders envisioned to be treated by the methods of the invention include, but are not limited to, hyperlipidemia, atherosclerosis, insulin resistance, diabetes, and hypertension. In particular, the invention provides for methods of identifying and using AGONISTS and ANTAGONISTS of RYZN activity, wherein said activity is selected from the group consisting of lipid partitioning, lipid metabolism, and insulin-like activity.
    Type: Application
    Filed: October 3, 2002
    Publication date: April 27, 2006
    Inventors: Deno Dialvnas, Aaron Scalia, John Lucas, Kristen Briggs
  • Krib polynucleotides and polypeptides and uses thereof in the treatment of metabolic disorders
    Publication number: 20060058507
    Abstract: The present invention relates to the field of metabolic research. KRIB polypeptides have been identified that are beneficial in the treatment of metabolic disorders. These compounds should be effective for reducing body mass and for treating metabolic disorders. These metabolic disorders include hyperlipidemia, atherosclerosis, diabetes, and hypertension.
    Type: Application
    Filed: May 5, 2003
    Publication date: March 16, 2006
    Applicant: GENSET S.A.
    Inventors: Kristen Briggs, Aaron Scalia, Carin Ribard
  • Gmg-3 gmg-4 and gmg-6 polynucleotides and polypeptides and uses thereof
    Publication number: 20050239696
    Abstract: The present invention relates to the field of metabolic research. Metabolic disorders, such as obesity, are a public health problem that is serious and widespread. GMG-3, GMG-4, Cluster 1, GMG-6A, or GMG-6B polypeptides have been identified that are beneficial in the treatment of metabolic disorders. These compounds should be effective for reducing body mass and for treating metabolic-related diseases and disorders. These metabolic-related diseases and disorders include hyperlipidemias, atherosclerosis, diabetes, and hypertension.
    Type: Application
    Filed: January 15, 2002
    Publication date: October 27, 2005
    Applicant: Genset S.A.
    Inventors: Mary Erickson, Barbara Chicca, Bernard Bihain, Hiroaki Tanaka, Tom Chu, Deno Dialynas, Aaron Scalia
  • Ngzipa,ngzipd,pgzipa and pgzipd polynucleotides and polypeptides and uses thereof
    Publication number: 20050065079
    Abstract: The present invention relates to the field of metabolic research. Metabolic disorders, such as obesity, are a public health problem that is serious and widespread. NGZIPA, NGZIPD, PGZIPA or PGZIPD polypeptides have been identified that are believed to be beneficial in the treatment of metabolic disorders. These compounds should be effective for reducing body mass and for treating metabolic-related diseases and disorders. These metabolic-related diseases and disorders include hyperlipidemias, atherosclerosis, diabetes, and hypertension.
    Type: Application
    Filed: October 3, 2002
    Publication date: March 24, 2005
    Inventors: Aaron Scalia, Deno Dialynas, Kristen Briggs